TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Shionogi & Co ( (JP:4507) ).
Shionogi & Co., Ltd. announced corrections to its Consolidated Financial Results for the second quarter of fiscal year 2025. The corrections involve numerical data related to the number of shares issued and treasury stock, as well as the pro forma information on revenue and profit from a business combination. These adjustments may impact stakeholders’ understanding of the company’s financial performance and projections.
The most recent analyst rating on (JP:4507) stock is a Buy with a Yen3119.00 price target. To see the full list of analyst forecasts on Shionogi & Co stock, see the JP:4507 Stock Forecast page.
More about Shionogi & Co
Shionogi & Co., Ltd. is a pharmaceutical company primarily engaged in the research, development, and marketing of pharmaceutical products. The company focuses on creating innovative medicines, with a strong presence in the Japanese market and a growing international footprint.
Average Trading Volume: 2,575,690
Technical Sentiment Signal: Buy
Current Market Cap: Yen2427.5B
Find detailed analytics on 4507 stock on TipRanks’ Stock Analysis page.